Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Display Modes
Old 08-01-2003, 01:28 AM   #1
Paul C.
Posts: n/a
Comments by Susan Love MD include:

"Researchers at the University of California Los Angeles recently reported the results of a study that put the FISH and the IHC tests head-to-head in the Journal of Clinical Oncology. The researchers performed both an IHC test and a FISH test on tumor samples from more than 850 women with stage I II or III breast cancer. When they compared the results they found that the IHC test produced a number of false positive tests. This meant that the IHC test showed the woman's tumor to be HER2/neu positive making her eligible for Herceptin when it really wasn't. When the same tumor was tested with the FISH method however it came up negative for HER2/neu overexpression indicating that Herceptin was not an appropriate treatment option."

  Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump

All times are GMT -7. The time now is 03:19 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2019, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter